Precision Biomonitoring Responds to Health Canada's Call for COVID-19 Research and Development with Innovative Point-of-Care Testing Solution
GUELPH, ON and MISSISSAUGA, ON, March 20, 2020 /CNW/ - Precision Biomonitoring, an industry leader in developing environmental DNA (eDNA) tools to detect organisms, announces the submission of its point-of-care SARS-CoV-2 Go-Strips and rapid mobile detection device to Health Canada for approval and use in Canada in response to the COVID-19 virus. The submission was based on lab validation data generated through testing viral samples and its on-going collaboration with major research institutions in Ontario and Manitoba, including with teams that recently identified and isolated the RNA of the new novel coronavirus.
"Our recent collaboration with healthcare and research institutions across the country positions us well to work with the Government of Canada and healthcare decision makers to provide innovative, point-of-care testing for COVID-19 in 60 minutes," says Dr. Mario Thomas, CEO, Precision Biomonitoring. "We are looking forward to playing our part in combatting this virus."
A proud Canadian company, Precision Biomonitoring, recognizes the importance of working with public health officials to ensure the safety of all Canadians. "Our technologies are inspired by our ongoing pursuit for innovation, and in the face of a rapidly evolving situation such as COVID-19, that relentless commitment is all the more critical," says Thomas. "To know that our company is working towards supporting healthcare professionals in enabling the diagnosis and care taking place across Canada continues to fuel our efforts. We look forward to a timely response from Health Canada."
Precision Biomonitoring has a demonstrated track record of being agile and adjusting to the scientific and medical needs of the Canadian landscape. Its ongoing work and strong existing relationships with the Government of Canada, as well as the Canadian Food Inspection Agency in the food safety and animal health space, has provided Precision Biomonitoring with the knowledge and experience necessary to be a trusted, collaborative partner to Health Canada.
About Precision Biomonitoring Founded in 2016 by a team of scientists from the University of Guelph's Biodiversity Institute of Ontario, Precision Biomonitoring provides TripleLock™ onsite eDNA surveillance platform solutions that give customers earlier detection of organisms for a more rapid response. Customers are any organizations that need onsite surveillance and rapid identification of any organism in any environment. The Precision Biomonitoring team is at the forefront of technological innovations in the genomics industry. Our vision is a world where we can identify any organism on the spot, in an instant, anywhere on the planet.
SOURCE Precision Biomonitoring
For further information: Media Contact: Meredith Adams, 416-459-7086, [email protected]